Huajin Dong

1.4k citations
45 papers · 1.2k indexed · h-index 21
Topics
Cancer Treatment and Pharmacology (11 papers)Cancer therapeutics and mechanisms (8 papers)Synthesis and Biological Evaluation (8 papers)
Partner nations
United StatesChinaTaiwan

In The Last Decade

Huajin Dong

44 papers receiving 1.1k citations

Peers

Huajin Dong
Comparison fields: 5 of 94
  • Organic Chemistry 730
  • Molecular Biology 414
  • Oncology 247
  • Pharmacology 143
  • Biomaterials 118
Replace Patricia Melnyk with:
Patricia Melnyk France
Pierfausto Seneci Italy
Ri-Zhen Huang China
Маргарита Е. Неганова Russia
Andriy I. Vovk Ukraine
Heeyeong Cho South Korea
Wiro M. P. B. Menge Netherlands
Salvatore Vomero Italy
Maurizio Anzini Italy
Anne Sophie Voisin‐Chiret France
Huajin Dong relative to Patricia Melnyk France Patricia Melnyk's profile →
Citations per field
00.5×2.7×
Patricia Melnyk · 1×
Citations per year

Countries citing papers authored by Huajin Dong

Since Specialization
Citations

This map shows the geographic impact of Huajin Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huajin Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huajin Dong more than expected).

Fields of papers citing papers by Huajin Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huajin Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huajin Dong. The network helps show where Huajin Dong may publish in the future.

Co-authorship network of co-authors of Huajin Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Huajin Dong. A scholar is included among the top collaborators of Huajin Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huajin Dong. Huajin Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 182
3 1
4 20
5 4
6 34
7 19
8 10
9 87
10 10
11 52
12 27
13 20
14
Iso-oxazole-Fludelone (KOS-1803) as a potent and efficacious microtubule-stablization epothilone against xenograft tumors.
1
15
Design, experimentation and computerized automated data analysis of synergistic drug combinations against xenograft tumors by Taxotere and T900607
7
16 30
17 23
18 41
19 50
20 23

About Huajin Dong

Huajin Dong is a scholar working on Toxicology, Organic Chemistry and Oncology, having authored 45 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Cancer therapeutics and mechanisms (8 papers) and Synthesis and Biological Evaluation (8 papers). The work is most often cited by research in Organic Chemistry (730 citations), Toxicology (51 citations) and Oncology (247 citations). Huajin Dong has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Ting‐Chao Chou, Samuel J. Danishefsky, Alexey Rivkin, Fumihiko Yoshimura, Ana E. Gabarda, Te‐Chang Lee, Rajesh Kakadiya, Tsann-Long Su, Anamik Shah and William P. Tong. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026